Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.

Also called NCT05431972

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 257 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05431972
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05431972. Randomized; no masking; primary purpose diagnostic. Start 2022-11-01 (actual); primary completion 2024-09-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement
Condition
Embolic Stroke of Undetermined Source
Intervention (Device)
Cardea SOLO
Intervention (Device)
12 Lead EKG
Lead sponsor
Asan Medical Center (class: other)

Record details

Record id
cardio:ct-nct05431972
Content hash
34dde06c8a96792320f82837f49e4b8e7eb78ccbd6e117966c25b021850257f0